Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Paxil Late-Listed Patents Are Questionable For Orange Book Listing – FTC

Executive Summary

Generic versions of Paxil are being held up by patents whose listing in the "Orange Book" is questionable, the Federal Trade Commission's generic drug report states

You may also be interested in...



AstraZeneca Fined $72 Mil. In Europe For Blocking Omeprazole Generic

AstraZeneca delayed market entry of omeprazole generics in Europe by supplying misleading patent information and deregistering the capsule formulation of its proton pump inhibitor Losec in certain countries, the European Commission said June 15

AstraZeneca Fined $72 Mil. In Europe For Blocking Omeprazole Generic

AstraZeneca delayed market entry of omeprazole generics in Europe by supplying misleading patent information and deregistering the capsule formulation of its proton pump inhibitor Losec in certain countries, the European Commission said June 15

“Authorized” Generics Are “Legitimate Business Strategy,” Pfizer Says

Pfizer views "authorized" generics as a sound business strategy following a drug's patent expiration, Senior Corporate Counsel Jeffrey Chasnow said during a Drug & Device Dialogue audio conference Oct. 7

Related Content

UsernamePublicRestriction

Register

PS040273

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel